myelodysplastic syndromes (MDS) | Page 17 | Aplastic Anemia and MDS International Foundation

myelodysplastic syndromes (MDS)

San Diego

Thank you for attending the 2016 San Diego Patient and Family Conference.

Event Date: 
Sat, 09/17/2016 -
8:30am to 4:30pm
Conference Event Type: 

Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the Europ

Potter VT, Iacobelli S, van Biezen A, Maertens J, Bourhis JH, Passweg JR, Yakhoub-Agha I, Tabrizi R, Bay JO, Chevallier P, Chalandon Y, Huynh A, Cahn JY, Ljungman P, Craddock C, Lenhoff S, Russell NH, Fegueux N, Socié G, Benedetto B, Meijer E, Mufti GJ
Primary Author: 
Potter VT
Journal Title: 
Biol Blood Marrow Transplant
Original Publication Date: 
Jun 2016

The European Society for Blood and Marrow Transplant Research data set was used to retrospectively analyze the outcomes of hypomethylating therapy (HMA) compared with those of conventional

Bone Marrow Diseases: